584 related articles for article (PubMed ID: 26623676)
41. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Low DE; McGeer A; Poon R
Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
[TBL] [Abstract][Full Text] [Related]
42. Methicillin-resistant
Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
[No Abstract] [Full Text] [Related]
43. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.
Natoli S; Fontana C; Favaro M; Bergamini A; Testore GP; Minelli S; Bossa MC; Casapulla M; Broglio G; Beltrame A; Cudillo L; Cerretti R; Leonardis F
BMC Infect Dis; 2009 Jun; 9():83. PubMed ID: 19497104
[TBL] [Abstract][Full Text] [Related]
44. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
Jørgen B; Merckoll P; Melby KK
Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
[TBL] [Abstract][Full Text] [Related]
45. Molecular characterization of methicillin-resistant Staphylococcus aureus resistant to tigecycline and daptomycin isolated in a hospital in Brazil.
Dabul AN; Camargo IL
Epidemiol Infect; 2014 Mar; 142(3):479-83. PubMed ID: 23714160
[TBL] [Abstract][Full Text] [Related]
46. Molecular and Phenotypic Characterization of Multidrug-Resistant Clones of Staphylococcus epidermidis in Iranian Hospitals: Clonal Relatedness to Healthcare-Associated Methicillin-Resistant Isolates in Northern Europe.
Saffari F; Widerström M; Gurram BK; Edebro H; Hojabri Z; Monsen T
Microb Drug Resist; 2016 Oct; 22(7):570-577. PubMed ID: 26981847
[TBL] [Abstract][Full Text] [Related]
47. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
[TBL] [Abstract][Full Text] [Related]
48. Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.
Seral C; Sáenz Y; Algarate S; Duran E; Luque P; Torres C; Castillo FJ
Int J Med Microbiol; 2011 Apr; 301(4):354-8. PubMed ID: 21236728
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.
Quiles-Melero I; Gómez-Gil R; Romero-Gómez MP; Sánchez-Díaz AM; de Pablos M; García-Rodriguez J; Gutiérrez A; Mingorance J
J Clin Microbiol; 2013 Mar; 51(3):998-1001. PubMed ID: 23269737
[TBL] [Abstract][Full Text] [Related]
50. Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus in bloodstream infections in patients of the Semmelweis University hospitals in Hungary.
Kristóf K; Kocsis E; Szabó D; Kardos S; Cser V; Nagy K; Hermann P; Rozgonyi F
Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):691-9. PubMed ID: 21222010
[TBL] [Abstract][Full Text] [Related]
51. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
[TBL] [Abstract][Full Text] [Related]
52. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
Mendes RE; Deshpande LM; Costello AJ; Farrell DJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4656-61. PubMed ID: 22687512
[TBL] [Abstract][Full Text] [Related]
53. In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci.
John MA; Pletch C; Hussain Z
J Antimicrob Chemother; 2002 Dec; 50(6):933-8. PubMed ID: 12461014
[TBL] [Abstract][Full Text] [Related]
54. Multidrug-resistant Staphylococcus haemolyticus isolates from infected eyes and healthy conjunctivae in India.
Panda S; Kar S; Sharma S; Singh DV
J Glob Antimicrob Resist; 2016 Sep; 6():154-159. PubMed ID: 27530859
[TBL] [Abstract][Full Text] [Related]
55. Antimicrobial susceptibility, biochemical and genetic profiles of Staphylococcus haemolyticus strains isolated from the bloodstream of patients hospitalized in critical care units.
Raponi G; Ghezzi MC; Gherardi G; Dicuonzo G; Caputo D; Venditti M; Rocco M; Micozzi A; Mancini C
J Chemother; 2005 Jun; 17(3):264-9. PubMed ID: 16038519
[TBL] [Abstract][Full Text] [Related]
56. In vitro bactericidal activity of daptomycin against staphylococci.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 2002 Mar; 49(3):467-70. PubMed ID: 11864946
[TBL] [Abstract][Full Text] [Related]
57. Staphylococcus epidermidis and Staphylococcus haemolyticus: detection of biofilm genes and biofilm formation in blood culture isolates from patients in a Brazilian teaching hospital.
Pinheiro L; Brito CI; Oliveira Ad; Pereira VC; Cunha Mde L
Diagn Microbiol Infect Dis; 2016 Sep; 86(1):11-4. PubMed ID: 27344542
[TBL] [Abstract][Full Text] [Related]
58. Double triplex real-time PCR assay for simultaneous detection of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus hominis, and Staphylococcus haemolyticus and determination of their methicillin resistance directly from positive blood culture bottles.
Kilic A; Basustaoglu AC
Res Microbiol; 2011 Dec; 162(10):1060-6. PubMed ID: 21925597
[TBL] [Abstract][Full Text] [Related]
59. In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Leuthner KD; Vidaillac C; Cheung CM; Rybak MJ
Antimicrob Agents Chemother; 2010 Sep; 54(9):3799-803. PubMed ID: 20585126
[TBL] [Abstract][Full Text] [Related]
60. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM
Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
